Member Info for Troutisout1

Cashintime,
These results are final results and the deadline would be 6 months, so end of June, so you were right, but not for the right reason. Interim Results have to be published within 3 months of the end of period.
A good set of results, plenty of cash still, now all eyes on whether they can get a partnering deal and the AI results on Influenza.

I am sure they are organising an Invesotr's Presentation but that will be afer the publication of Full Year results which Mo did say they were hopin gto release in April. If that is the case, we are well in a closed period and I wouldn't expect them to do anything but release material news as it happens, releasing upbeat reassurance just to placate the half a dozen shareholders (who do actually hold and are not just trying to incite some panic) on some financial BBs will not happen.
Be patient , the results will answer lots of things. Just a few days left before the new Tax Year as well...

Not sure it is Magoo, but certainly should be....

Bloody amazing how a couple of posters on different sites can bring back the CF whinges and everyone turns negative....Does no-one move on?

Yes it has, the value if each trial has increased materially, the EBITDA has increased as pointed out in the trading update, they have made big efficiencies in the recruitment of volunteers and the amount of clinic beds and the ability to run more than one trial concurrently.
The results should be out next month and then we can all see the margins.

It would seem Colin60 is here to just drag out some negatives and moan a lot.....

Just reading the posts on this thread and seen the late reported trade yesterday afternoon.....I wonder if the MMs could have sold those at 8.2p, without dropping the price below and taking shares over the previous day or so?
Nearly 1m more buys yesterday than sells and yet the price closed where it opened.
Perhaps there is room for both hypotheses and the balancing MMs do, is done over a period of time, not daily...

FINTECH, DKE didn't sell anything to Masdar, the Arlington Company was sold by Arlington, it just happens tht DKE had a SPV with Arlington (that has since sold their two assets) and that both companies shared Directors.
My take was the Arlington DKE link up was to get some funds as Arlington seemed forever skint (even though they posted about financing), they were going to use the DKE listing to raise funds, but that failed dismally with first the CLN and then some of the loans being changed. Both DKE and Arlington had no funds and no obvious was of raising more. While they play around with investors here, Masdar has come in and bought the Arlington assets, Masdar is financially huge and as a State owned Co. won't need a listing on the LSE, so DKE has been left at the altar and the congregation are left waiting for something to happen, meanwhile the bridesmaids (Clare and Gazzard) have gone off to celebrate the other wedding with the new partner without a thought about everyone. Great, Great Uncle Geoffrey has been left with an expensive loan conversion and is wondering how to keep going until retirement (he is now 76 years old)

Colin,
When we are talking about commercial contracts, of course they cannot RNS all the details and costs, they could prejudice other clients and further business by doing so.
Half the problem is PIs want to try and do their own detective work and come up with answer (I am guilty of this), it is in the nature of an investor to try and get to the bottom of things. Rarely though can we, as the Company will not want to publish details of contracts.
My take is still this has been known for a long time now and it was just the Vaxart Results and the statement within that would have spooked the same PIs, that led to HVO having to clarify by RNS the next morning. I applaud HVO for doing so in a timely manner, rather than wait a day or so.
From the contract we know that HVO are covered, however there would have been no Challenge Study booked before the Model was developed and then there would have been a Characterisation Study first, before any Challenge Study, so the lack of dates in the contract posted means none of us can actually know what was contracted and what wasn't.

Greend, I had originally thought that but the AIM Immunotech trial was cancelled in the Autumn of 2021, so would not be in last year's figures as the deposit is received when the trial is booked, which was Summer 2021. They may have to wait to book the cancellation into the accounts I don't know.
What I was basing my supposition on earlier, was the fact that back in the trading update and subsequent interviews this Vaxart contract wasn't in the booked pipeline figure.
I did re-read the Vaxart contract the other day and I believe the Challenge trial (and maybe the characteriastion trial) were dependent on another party co-sponsoring . Will have to look again tonight.

As you will read in the trading update from late January, they knew about this then, this RNS is due to the Vaxart results being released yesterday and their statement about it,
"In addition, recognition of postponement and cancellation fees for an aggregate of over GBP1 million had a one-time positive impact on EBITDA. "
The good thing is Vaxart has paid the usual deposits and they will have been forfeited, this in turn means more space at some point in the quarantine for other trials and that the Company has continued with developing the Omicron Challenge Agent. This will be a money spinner in the future and keeps them at the forefront of any Covid Challenge Studies.

HVO had risen 130% since the New Year started, some sort of pullback and top slicing was inevitable at some point and together with a lack of newsflow over the last 5 weeks it was to be expected. Also we were heavily tipped in the latter of 2022 and earlier this year, many of the targets printed were hit and therefore there will have been profit taking from those that bought in on the tips.
More sellers than buyers? Recently yes, however there are two things missing in that argument, firstly that the sellers probably haven't outweighed the buyers on the rise, so it is in MMs interests to try and draw out more. Secondly one of the ways is to put both sells and buys through below mid so showing an inflated sell volumn, which in turn allows for people to believe there are far more sells than buys.
Then we have the SVB collapse, that should not affect HVO, however the whole market is affected whether directly or indirectly and let's just say if you were MMs trying to balance your books or even building up some stock for the next move up, the SVB market concern can help you to get more sellers out.
Lastly there have been a few rollovers and transfers go through and these will accelerate as we get closer to 5th April, as will anyone looking to crystallize their position by selling.
The reasons people were tipping this and buying haven't gone away,, the market is at best flakey at the moment, HVO is in a great position but all boats drop when the tide goes out and that is currently happening, there will be opportunities for some to get more/buy in before any further rise and I believe that won't be far away.

Then he is still wildly wrong, 4p would be closer to £27m not £2.5m.

No likely to be a transfer, so one is a sell and the other a buy.

Shroders have gone down 647k over a period of time, certainly not all yesterday.
These two trades at HVO and POLB were seconds apart which might suggest the same investor selling both.

Looks like someone has taken their cards off the table in both HVO and POLB with a large sell in both at 16.00hrs (£165k HVO and £97k POLB). Tax reasons or just liquidating positions? Who Knows? It gives the MMs some more shares.

Looks like someone has taken their cards off the table in both HVO and POLB with a large sell in both at 16.00hrs (£165k HVO and £97k POLB). Tax reasons or just liquidating positions? Who Knows? It gives the MMs some more shares.

I would say Scinv has proved beyond doubt what he is and it is now obvious to everyone that he cannot do basic arithmetic.

approx 670m shares in issue,
£1 divi would be £670m
10p divi would be £67m
1p divi would be £6.7m
0.1p divi would be £670k
0.05p divi would be £335k

Now what did he say?
"Lmao you can't even handle simple arithmetics and you gamble in the stock market. I hope you don't have people who depend on you."
Hilarious!

No that is a transfer done at mid price, from one account/broker to another account/broker, likely to be end of year tax planning.

So this morning has seen the rebound continue and MMs have sold most of the shares they accumulated yesterday (netting themselves a decent turn). The price was pushed up, with the bid raised to attract some selling, the spread was widened and now both buys and sells are going through as sells, in a bid to scare more sellers out. A positive sign and I believe there is more to go with this current rise...